DOUBLE MARKER (Prisca)

Introduction to the Double Marker Test

The double marker test is a prenatal screening method used to assess the risk of chromosomal abnormalities in the fetus. It is typically conducted during the first trimester of pregnancy and is a crucial part of early prenatal care.

How the Test Works

This test measures the levels of two specific proteins in the mother’s blood: free beta human chorionic gonadotropin (free beta-hCG) and pregnancy-associated plasma protein A (PAPP-A). The results are combined with the mother’s age and other factors to calculate the risk of conditions like Down syndrome and Edwards syndrome.

Importance of the Double Marker Test

The double marker test is non-invasive and provides valuable information about the baby’s health without posing any risk to the mother or fetus. It helps expectant parents make informed decisions and prepare for any potential challenges. Always consult with your healthcare provider to understand the implications of the test results.